ANDERSSON, Emma, Lenka BRYJOVÁ, Kristin BIRIS, Terry YAMAGUCHI, Ernest ARENAS and Vítězslav BRYJA. Genetic Interaction Between Lrp6 and Wnt5a During Mouse Development. Developmental dynamics. United States: Wiley-Liss, 2010, vol. 2010, No 239, 9 pp. ISSN 1058-8388.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Genetic Interaction Between Lrp6 and Wnt5a During Mouse Development
Name in Czech Genetická interakce mezi Lrp6 a Wnt5a během vývoje myši
Authors ANDERSSON, Emma (752 Sweden), Lenka BRYJOVÁ (203 Czech Republic), Kristin BIRIS (752 Sweden), Terry YAMAGUCHI (840 United States of America), Ernest ARENAS (724 Spain) and Vítězslav BRYJA (203 Czech Republic, guarantor).
Edition Developmental dynamics, United States, Wiley-Liss, 2010, 1058-8388.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.864
RIV identification code RIV/00216224:14310/10:00043604
Organization unit Faculty of Science
UT WoS 000273703900021
Keywords in English Wnt5a; Lrp6; somitogenesis; development
Changed by Changed by: prof. Mgr. Vítězslav Bryja, Ph.D., učo 11088. Changed: 14/4/2010 12:51.
Abstract
Lrp6 is generally described as a receptor required for signal transduction in the Wnt/b-catenin pathway. Wnt5a, however, is a Wnt ligand which usually does not activate Wnt/b-catenin but rather activates non-canonical Wnt signaling. Here we describe phenotypes found in Wnt5a/Lrp6 compound mutant mice, including a worsening of individual Wnt5a or Lrp6 loss of function phenotypes. Lrp6 haploinsufficiency in a Wnt5a-/- background caused spina bifida and exacerbated posterior truncation.
Links
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 24/7/2024 07:23